866-997-4948(US-Canada Toll Free)

Global Pharmaceutical Supplier Industry Outlook Survey 20112012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies

Published By :

ICD Research

Published Date : Jul 2011

Category :

Advertising and Marketing

No. of Pages : 119 Pages

Synopsis

Analysis of opinions drawn from leading pharmaceutical industry executives 
Analysis on how pharmaceutical companies media spend, marketing and sales strategies and practices are set to change in 20112012
Analysis on spending plans, media budget allocations, challenges and sales strategies of leading pharmaceutical industry suppliers

Summary

This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leading pharmaceutical industry executives. It analyzes how pharmaceutical industry suppliers media spend, marketing and sales strategies and business practices are set to change in 20112012. This report gives you access to media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading suppliers. The report also identifies future growth of buyers and suppliers, M&A and investment expectations. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Scope

  • The opinions and forward looking statements of 764 industry executives have been captured in our in-depth survey, of which 41% represent Director and C-level respondents
  • The report is based on primary research conducted by ICD Research accessing its B2B panels comprised of senior marketing decision makers and leading supplier organizations
  • The geographical scope of the research is global drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa and Middle East
  • In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats
  • Key topics covered include media spend activity, marketing and sales behaviors and strategies by suppliers, as well as threats and opportunities, investment outlook and business confidence among both buyers and suppliers.
  • The report examines current practices and provides future expectations over the next 12-24 months
  • The report provides qualitative analysis of the key industry threats and opportunities and contains full survey results
  • This report covers data and analysis on media channel expenditure, marketing and sales practices and industry developments by suppliers
Reasons To Buy

  • Benchmark your sales and marketing spend with industry peers to effectively determine strategy
  • Identify the specific marketing approaches and pricing patterns your competitors are using to win business 
  • Better promote your business by aligning your capabilities and business practices with your customers changing needs during these times of market uncertainty
  • Predict how the industry will grow, consolidate and where it will stagnate
  • Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers in the industry
Key Highlights

China, India and Brazil are predicted to be the fastest growing regions among developing countries for the pharmaceutical industry. An aging population, growth of chronic diseases, expanding healthcare insurance coverage, urbanization and increasing investment in rural healthcare services are major drivers for growth. A total of XX.XX% of respondents expect their companies to increase their marketing expenditure over the next 12 months, with only XX.XX% looking to decrease it. Overall, XX.XX% of respondents from the supplier industry consider ability to target specific audience niches to be a key factor in selection of a marketing vendor.
Table Of Content

1 Introduction

1.1 What is this report about?
1.2 Definitions
1.3 Methodology
1) Online Survey
2) Secondary Research
3) Data Analysis and Report Writing
4) Quality Control
1.4 Profile of survey respondents
1.4.1 Profile of buyer respondents
1.4.2 Profile of supplier respondents

2 Executive Summary

3 Industry Dynamics
3.1 Revenue growth expectations
3.1.1 Revenue growth expectations by company type
3.1.2 Revenue growth expectations by region
3.1.3 Revenue growth expectations by turnover
3.1.4 Revenue growth expectations by senior level respondents
3.1.5 Revenue growth expectations: cross industry comparisons
3.2 Future developments in business structure
3.2.1 Future developments by buyers
3.2.2 Future developments by suppliers
3.3 M&A activity predictions
3.3.1 M&A activity predictions by buyers
3.3.2 M&A activity predictions by suppliers
3.3.3 M&A activity predictions by region
3.3.4 M&A activity predictions by company turnover
3.3.5 M&A activity expectations vs. expansion abroad

4 Pharmaceutical Market Growth Outlook
4.1 Demand in emerging markets
4.1.1 Demand in emerging markets by buyers
4.1.2 Demand in emerging markets by suppliers
4.1.3 Demand in emerging markets by region
4.1.4 Demand in emerging markets by company turnover
4.2 Growth expectations in developed countries
4.2.1 Growth expectations in developed countries by buyers
4.2.2 Growth expectations in developed countries by suppliers
4.2.3 Growth expectations in developed countries by region
4.2.4 Growth expectations in developed countries by company turnover

5 Threats And Opportunities for the Pharmaceutical Industry
5.1 Leading business concerns for 20112012
5.1.1 Leading business concerns for the period by company type
5.1.2 Leading business concerns by region
5.1.3 Leading business concerns by company turnover
5.2 Key supplier actions to maintain and win buyer business
5.2.1 Actions to maintain and secure buyer business by buyers
5.2.2 Actions to maintain and secure buyer business by region
5.2.3 Actions to maintain and secure buyer business by turnover
5.2.4 Actions to maintain and secure buyer business by procurement budget
5.2.5 Actions to maintain and secure buyer business by purchasing decision authority

6 Pharmaceutical Industry Supplier Marketing Spend Activity
6.1 Annual marketing budgets: pharmaceutical industry suppliers
6.1.1 Annual marketing budgets by region
6.1.2 Annual marketing budgets by company turnover
6.2 Planned change in marketing expenditure levels
6.2.1 Planned change in marketing expenditure levels by region
6.2.2 Planned change in marketing expenditure levels by company turnover
6.2.3 Planned change in marketing expenditure levels by revenue growth expectations (%), 2011
6.3 Future investment by media channel
6.3.1 Future investment by media channel by region
6.3.2 Future investment by media channel by company turnover
6.4 Suppliers' future investment in marketing and sales technology
6.4.1 Planned investment in marketing and sales technologies by region
6.4.2 Planned investment in marketing and sales technologies by company turnover

7 Marketing and Sales Behaviors and Strategies in 2011-2012
7.1 Key marketing aims of suppliers for 201112
7.1.1 Key marketing aims by region
7.1.2 Key marketing aims by company turnover
7.1.3 Key marketing aims by revenue growth expectations
7.2 Essential amendments to marketing activities in 201112
7.2.1 Amendments to marketing activities by region
7.2.2 Amendments to marketing activities by company turnover
7.3 Use of new media for business prospects
7.3.1 Use of new media by region
7.3.2 Use of new media by company turnover
7.4 Critical success factors for choosing a marketing agency
7.4.1 Critical success factors: by region
7.4.2 Critical success factors: by company turnover

8 Appendix
8.1 Full survey results closed questions
8.2 Methodology
8.3 Contact us
8.4 About ICD Research
8.5 Disclaimer

List of Table

Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2011
Table 2: Buyer Respondents by Job Role (%), 2011
Table 3: Buyer Respondents by Company Turnover (%), 2011
Table 4: Buyer Respondents by Total Number of Employees in Organizations (%), 2011
Table 5: Buyer Respondents by Region (%), 2011
Table 6: Supplier Respondents by Job Role (%), 2011
Table 7: Supplier Respondents by Company Turnover (%), 2011
Table 8: Supplier Respondents by Total Number of Employees in Organizations (%), 2011
Table 9: Supplier Respondents by Region (%), 2011
Table 10: Revenue Growth Optimism (%), 20092011
Table 11: Revenue Growth Optimism by Buyers (%), 20092011
Table 12: Revenue Growth Optimism by Suppliers (%), 20092011
Table 13: Revenue Growth Optimism by Region (%), 20092011
Table 14: Revenue Growth Optimism by Turnover (%), 2011
Table 15: Revenue Growth Optimism by Senior Level Respondents (%), 2011
Table 16: Key Changes In Business Structure in the Pharmaceutical Manufacturer Industry (%), 2011
Table 17: Key Changes In Business Structure in the CRO and CMO Industry (%), 2011
Table 18: Key Changes In Business Structure in the Drug Manufacturing Supplier Industry (%), 2011
Table 19: M&A Expectations Pharmaceutical Manufacturer Industry, 20092011
Table 20: M&A Expectations CRO and CMO Industry, 20092011
Table 21: M&A Expectations Drug Manufacturing Supplier Industry, 20092011
Table 22: M&A Expectations by Region, 2011
Table 23: M&A Expectations by Company Turnover, 2011
Table 24: M&A Activity Expectations vs. Expand Abroad (%), 2011
Table 25: Demand in Emerging Markets by Pharmaceutical Manufacturer (%), 2011
Table 26: Demand in Emerging Markets by CRO and CMO Industry (%), 2011
Table 27: Demand in Emerging Markets by Drug Manufacturing Supplier (%), 2011
Table 28: Growth Expectations in Developed Countries by Pharmaceutical Manufacturer (%), 2011
Table 29: Growth Expectations in Developed Countries by CRO and CMO (%), 2011
Table 30: Growth Expectations in Developed Countries by Drug Manufacturing Supplier (%), 2011
Table 31: Leading Business Concerns (%), 20092010, 20102011,20112012
Table 32: Leading Business Concerns by Company Type (%), 20112012
Table 33: Leading Business Concerns by Region (%), 20112012
Table 34: Leading Business Concerns by Company Turnover (%), 20112012
Table 35: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2011
Table 36: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2011
Table 37: Actions to Maintain and Secure Buyer Business by Region (%), 2011
Table 38: Actions to Maintain and Secure Buyer Business by Procurement Budget (%), 2011
Table 39: Annual Marketing Budgets: Drug Manufacturing Industry Suppliers (%), 20092011
Table 40: Annual Marketing Budgets by Region (%), 2011
Table 41: Annual Marketing Budgets by Company Turnover (%), 2011
Table 42: Planned Change in Marketing Expenditure Levels: Suppliers (%), 20092011
Table 43: Planned Change in Marketing Expenditure Levels by Region (%), 20092011
Table 44: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2011
Table 45: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2011
Table 46: Future Investment by Media Channels : Drug Manufacturing Industry Suppliers, 2011
Table 47: Planned Investment in Marketing and Sales Technologies (% Suppliers), 2011
Table 48: Planned Investment in Marketing and Sales Technologies by Region (%), 2011
Table 49: Planned Investment in Marketing and Sales Technologies by Company Turnover (%), 2011
Table 50: Key Marketing Aims: Drug Manufacturing Industry Suppliers (%), 2011
Table 51: Amendments to Marketing Activities (% Suppliers), 2011
Table 52: Amendments to Marketing Activities by Region (%), 2011
Table 53: Amendments to Marketing Activities by Company Turnover (%), 2011
Table 54: Use of New Media by Suppliers (%), 2011
Table 55: Use of New Media by Region (% ), 2011
Table 56: Use of New Media by Company Turnover (% ), 2011
Table 57: Critical Success Factors: Drug Manufacturing Industry Suppliers (%), 20092011
Table 58: Critical Success Factors by Region (%), 2011
Table 59: Critical Success Factors by Company Turnover (%), 2011
Table 60: Full survey results closed questions

List of Chart

Figure 1: Revenue Growth Optimism (%), 20092011
Figure 2: Revenue Growth Optimism by Company Type(%), 20092011
Figure 3: Revenue Growth Optimism by Region (%), 20092011
Figure 4: Revenue Growth Optimism by Turnover (%), 2011
Figure 5: Revenue Growth Optimism by Senior Level Respondents (%), 2011
Figure 6: Company Revenue Growth Optimism: Cross Industry Comparisons (%), 2011
Figure 7: Key Changes In Business Structure in the Pharmaceutical Manufacturer Industry (%), 2011
Figure 8: Key Changes In Business Structure in the CRO and CMO Industry (%), 2011
Figure 9: Key Changes In Business Structure in the Drug Manufacturing Supplier Industry (%), 2011
Figure 10: M&A Expectations Pharmaceutical Manufacturer Industry, 20092011
Figure 11: M&A Expectations CRO and CMO Industry, 20092011
Figure 12: M&A Expectations Drug Manufacturing Supplier Industry, 20092011
Figure 13: M&A Expectations by Region, 2011
Figure 14: M&A Expectations by Company Turnover, 2011
Figure 15: Top Ten Growth Regions (%), 2011
Figure 16: Top Five Emerging Markets, 2011
Figure 17: Demand in Emerging Markets by Pharmaceutical Manufacturer (%), 2011
Figure 18: Demand in Emerging Markets by CRO and CMO Industry (%), 2011
Figure 19: Demand in Emerging Markets by Region (%), 2011
Figure 20: Demand in Emerging Markets by Company Turnover (%), 2011
Figure 21: Top Five Developed Countries Targeted for Growth, 2011
Figure 22: Growth Expectations in Developed Countries by Pharmaceutical Manufacturer (%), 2011
Figure 23: Growth Expectations in Developed Countries by CRO and CMO (%), 2011
Figure 24: Growth Expectations in Developed Countries by Drug Manufacturing Supplier (%), 2011
Figure 25: Growth Expectations in Developed Countries by Region (% 'Increase' Responses), 2011
Figure 26: Growth Expectations in Developed Countries by Turnover (% 'Increase' Responses), 2011
Figure 27: Leading Business Concerns (%), 20112012
Figure 28: Leading Business Concerns (%), 20112012
Figure 29: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2011
Figure 30: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2011
Figure 31: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2011
Figure 32: Actions to Maintain and Secure Buyer Business by Purchasing Decision Authority (%), 2011
Figure 33: Annual Marketing Budgets: Drug Manufacturing Industry Suppliers (%), 20092011
Figure 34: Annual Marketing Budgets by Region (%), 2011
Figure 35: Annual Marketing Budgets by Company Turnover (%), 2011
Figure 36: Planned Change in Marketing Expenditure Levels: Suppliers (%) , 20092011
Figure 37: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2011
Figure 38: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2011
Figure 39: Future Investment by Media Channels : Drug Manufacturing Industry Suppliers, 2011
Figure 40: Future Investment by Media Channels by Region (% Increase Responses), 2011
Figure 41: Future Investment by Media Channels by Company Turnover (% Increase Responses), 2011
Figure 42: Planned Investment in Marketing and Sales Technologies (% Suppliers), 2011
Figure 43: Planned Investment in Marketing and Sales Technologies by Region (%), 2011
Figure 44: Planned Investment in Marketing and Sales Technologies by Company Turnover (%), 2011
Figure 45: Key Marketing Aims: Drug Manufacturing Industry Suppliers (%), 2011
Figure 46: Key Marketing Aims by Region (%), 2011
Figure 47: Key Marketing Aims by Company Turnover (%), 2011
Figure 48: Key Marketing Aims by Revenue Growth Expectations (%), 2011
Figure 49: Amendments to Marketing Activities (% Suppliers), 2011
Figure 50: Amendments to Marketing Activities by Region (%), 2011
Figure 51: Amendments to Marketing Activities by Company Turnover (%), 2011
Figure 52: Use of New Media by Suppliers (%), 2011
Figure 53: Use of New Media by Company Turnover (% ), 2011
Figure 54: Critical Success Factors: Drug Manufacturing Industry Suppliers (%), 2011

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *